n-(3-(aminomethyl)benzyl)acetamidine has been researched along with tat-nr2b9c in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beamer, E; Beynon, RJ; Hammond, D; Salter, MW; Sills, GJ; Simpson, D; Thippeswamy, T; Tse, K; Tymianski, M | 1 |
1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and tat-nr2b9c
Article | Year |
---|---|
The impact of postsynaptic density 95 blocking peptide (Tat-NR2B9c) and an iNOS inhibitor (1400W) on proteomic profile of the hippocampus in C57BL/6J mouse model of kainate-induced epileptogenesis.
Topics: Amidines; Animals; Anticonvulsants; Benzylamines; Epilepsy; Hippocampus; Kainic Acid; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Peptides; Proteomics; Status Epilepticus | 2019 |